文献速递头颈外科咽喉与嗓音

血管靶向磷酸钛氧钾激光微创手术治疗早期喉癌后功能嗓音结局的随机对照单盲临床试验

Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer.
PubMed 文献 · Head Neck · 2019-01-31

这项前瞻性随机单盲临床II期对照研究比较了微血管消融磷酸钛氧钾(KTP)激光与CO2激光经口激光显微手术(TLM)治疗早期声门癌的嗓音功能结局,主要终点为6个月随访期内嗓音障碍指数(VHI-30)问卷评分,次要终点为局部控制率。结果显示自9周随访起TLM-KTP组VHI评分显著低于TLM-CO2组,TLM-KTP组无复发而TLM-CO2组出现1例复发。作者认为需开展更大样本的多中心II期或III期研究。

要点

  • 自9周随访起,TLM-KTP组VHI评分较TLM-CO2组显著降低。
  • 6个月内TLM-KTP组无复发,TLM-CO2组出现1例复发。
  • 作者认为需开展更大样本多中心II期或III期研究。

核心结论

  • 作者认为早期声门癌TLM-KTP术后嗓音结局或局部控制率需开展纳入更大患者队列的多中心II期或III期研究。

研究设计与样本

  • 前瞻性、随机、单盲、设对照组的临床II期研究,主要终点为6个月随访期内VHI-30问卷评估的嗓音结局,次要终点为局部控制率。
  • 纳入单侧高级别异型增生、原位癌或早期声门癌患者,接受TLM-KTP者n=8,接受TLM-CO2者n=12。

主要发现

  • 自9周随访访视起,TLM-KTP组VHI评分较TLM-CO2组显著降低。
  • 6个月内TLM-KTP组无复发,TLM-CO2组出现1例复发。

关键数值与推荐

  • 主要终点为6个月随访期内VHI-30问卷评估的嗓音结局。
  • 次要终点为局部控制率。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为需开展纳入更大患者队列的多中心II期或III期研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Local control rate (LCR) of early glottic cancer is high after radiation therapy or transoral laser microsurgery (TLM). The aim of this study was to investigate functional voice outcome after TLM using a microvessel-ablative potassium-titanyl-phosphate (KTP) laser in comparison with a gold standard cutting CO2 laser. METHODS: The primary end point of this prospective, randomized, single-blinded, clinical phase II study with control group was voice outcome during a follow-up of 6 months assayed by Voice Handicap Index (VHI-30)-questionnaires in patients with unilateral high-grade dysplasia, carcinoma in situ or early glottic cancer undergoing TLM-KTP (n = 8) or TLM-CO2 (n = 12). The secondary end point was LCR. RESULTS: Starting from the 9-week-follow-up visit, TLM-KTP yielded significantly reduced VHI scores compared to TLM-CO2 . No relapse occurred after TLM-KTP in contrast to one recurrence after TLM-CO2 within 6 months. CONCLUSION: Multicenter phase II or III studies on voice outcome or local control rate after TLM-KTP in early glottic cancer are warranted enrolling larger patient cohorts.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Strieth S, Ernst BP, Both I, et al. Randomized controlled single-blinded clinical trial of functional voice outcome after vascular targeting KTP laser microsurgery of early laryngeal cancer. Head Neck. 2019. PMID: 30702173. doi:10.1002/hed.25474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。